Skip to main content
Biomolecules & Therapeutics logoLink to Biomolecules & Therapeutics
. 2024 Mar 1;32(2):261. doi: 10.4062/biomolther.2024.002

Erratum to "Tanshinone IIA Protects Endothelial Cells from H2O2-Induced Injuries via PXR Activation" [Biomol Ther 25(6), 599-608 (2017)]

Haiyan Zhu 1,2, Zhiwu Chen 1, Zengchun Ma 2, Hongling Tan 2, Chengrong Xiao 2, Xianglin Tang 2, Boli Zhang 3, Yuguang Wang 1,2,*, Yue Gao 1,2,*
PMCID: PMC10902709  PMID: 38412976

Upon reviewing our published work, we realized that the representative images of the Rifampicin (RIF) group in Fig. 6A were found to be misplaced due to mishandling in the manuscript preparation.

To rectify this error, we have prepared the correct versions of these figures shown below.

Fig. 6.

Fig. 6.

(A) Tan IIA inhibits H2O2-induced inflammation via PXR activation.


Articles from Biomolecules & Therapeutics are provided here courtesy of Korean Society of Applied Pharmacology

RESOURCES